• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床中 ATTR 淀粉样变的筛查:重叠性疾病、误诊和多器官意识。

Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness.

机构信息

Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, USA.

Department of Neurology, Oregon Health & Science University, Portland, OR, USA.

出版信息

Heart Fail Rev. 2022 May;27(3):785-793. doi: 10.1007/s10741-021-10080-2. Epub 2021 Feb 20.

DOI:10.1007/s10741-021-10080-2
PMID:33609196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9033715/
Abstract

Amyloid transthyretin (ATTR) amyloidosis is a clinically heterogeneous and fatal disease that results from deposition of insoluble amyloid fibrils in various organs and tissues, causing progressive loss of function. The objective of this review is to increase awareness and diagnosis of ATTR amyloidosis by improving recognition of its overlapping conditions, misdiagnosis, and multiorgan presentation. Cardiac manifestations include heart failure, atrial fibrillation, intolerance to previously prescribed antihypertensives, sinus node dysfunction, and atrioventricular block, resulting in the need for permanent pacing. Neurologic manifestations include progressive sensorimotor neuropathy (e.g., pain, weakness) and autonomic dysfunction (e.g., erectile dysfunction, chronic diarrhea, orthostatic hypotension). Non-cardiac red flags often precede the diagnosis of ATTR amyloidosis and include musculoskeletal manifestations (e.g., carpal tunnel syndrome, lumbar spinal stenosis, spontaneous rupture of the distal tendon biceps, shoulder and knee surgery). Awareness and recognition of the constellation of symptoms, including cardiac, neurologic, and musculoskeletal manifestations, will help with early diagnosis of ATTR amyloidosis and faster access to therapies, thereby slowing the progression of this debilitating disease.

摘要

淀粉样变转甲状腺素蛋白(ATTR)淀粉样变性是一种临床表现多样且致命的疾病,由不溶性淀粉样纤维在各种器官和组织中沉积导致,从而引起进行性功能丧失。本文的目的是通过提高对其重叠病症、误诊和多器官表现的认识,提高对 ATTR 淀粉样变性的认识和诊断,心脏表现包括心力衰竭、心房颤动、对先前开的降压药不耐受、窦房结功能障碍和房室传导阻滞,导致需要永久性起搏。神经表现包括进行性感觉运动神经病(例如,疼痛、无力)和自主神经功能障碍(例如,勃起功能障碍、慢性腹泻、直立性低血压)。非心脏性红色标志通常先于 ATTR 淀粉样变性的诊断,包括肌肉骨骼表现(例如,腕管综合征、腰椎狭窄、肱二头肌远端肌腱自发性破裂、肩部和膝关节手术)。对包括心脏、神经和肌肉骨骼表现在内的一系列症状的认识和认识将有助于早期诊断 ATTR 淀粉样变性,并更快地获得治疗,从而减缓这种使人衰弱的疾病的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/b10935be6a64/10741_2021_10080_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/e1a01ed08103/10741_2021_10080_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/d5d4766ca4c2/10741_2021_10080_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/ad50c32782eb/10741_2021_10080_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/b10935be6a64/10741_2021_10080_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/e1a01ed08103/10741_2021_10080_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/d5d4766ca4c2/10741_2021_10080_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/ad50c32782eb/10741_2021_10080_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e233/9033715/b10935be6a64/10741_2021_10080_Fig4_HTML.jpg

相似文献

1
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness.临床中 ATTR 淀粉样变的筛查:重叠性疾病、误诊和多器官意识。
Heart Fail Rev. 2022 May;27(3):785-793. doi: 10.1007/s10741-021-10080-2. Epub 2021 Feb 20.
2
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.改善多发性神经病ATTR 淀粉样变症诊断的专家共识建议。
J Neurol. 2021 Jun;268(6):2109-2122. doi: 10.1007/s00415-019-09688-0. Epub 2020 Jan 6.
3
Musculoskeletal co-morbidities in patients with transthyretin amyloid cardiomyopathy: a systematic review.转甲状腺素蛋白淀粉样心肌病患者的肌肉骨骼合并症:系统评价。
ESC Heart Fail. 2024 Apr;11(2):662-671. doi: 10.1002/ehf2.14622. Epub 2023 Dec 21.
4
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.避免误诊:全科医生对转甲状腺素蛋白淀粉样变性的疑诊和诊断的专家共识建议。
BMC Fam Pract. 2020 Sep 23;21(1):198. doi: 10.1186/s12875-020-01252-4.
5
[Neurological manifestations of ATTR amyloidosis].[转甲状腺素蛋白淀粉样变性的神经学表现]
Inn Med (Heidelb). 2023 Sep;64(9):848-854. doi: 10.1007/s00108-023-01570-6. Epub 2023 Aug 9.
6
Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.淀粉样变心肌病:转甲状腺素蛋白淀粉样变性的临床谱扩大——病例报告及文献复习。
J Nucl Cardiol. 2023 Aug;30(4):1420-1426. doi: 10.1007/s12350-022-02990-x. Epub 2022 May 17.
7
Same same, but different? The neurological presentation of wildtype transthyretin (ATTRwt) amyloidosis.一样又不一样?野生型转甲状腺素蛋白(ATTRwt)淀粉样变的神经表现。
Amyloid. 2022 Jun;29(2):92-101. doi: 10.1080/13506129.2021.2014448. Epub 2022 Jan 7.
8
Neuromuscular Complications of Systemic Amyloidosis.系统性淀粉样变的神经肌肉并发症。
Am J Med. 2022 Apr;135 Suppl 1:S13-S19. doi: 10.1016/j.amjmed.2022.01.006. Epub 2022 Jan 31.
9
Technetium-pyrophosphate scintigraphy: a practical guide for early diagnosis of transthyretin amyloid cardiomyopathy.锝焦磷酸盐闪烁扫描术:转甲状腺素淀粉样变心肌病早期诊断的实用指南。
ESC Heart Fail. 2022 Feb;9(1):251-262. doi: 10.1002/ehf2.13693. Epub 2021 Nov 29.
10
Hand surgeons and amyloidosis specialists warning: transthyretin-associated amyloidosis with bifid median nerve as a cause of bilateral carpal tunnel syndrome. A case report and literature review.手外科医生和淀粉样变性病专家警告:以正中神经分支为病因的转甲状腺素蛋白相关性淀粉样变性病导致双侧腕管综合征。病例报告及文献综述。
Eur J Orthop Surg Traumatol. 2022 Apr;32(3):575-581. doi: 10.1007/s00590-021-03004-1. Epub 2021 May 29.

引用本文的文献

1
Genetic testing and evidence of a founder mutation in a hotspot for hereditary transthyretin amyloidosis.遗传性转甲状腺素蛋白淀粉样变性热点区域的基因检测及奠基者突变证据
Sci Rep. 2025 Aug 14;15(1):29773. doi: 10.1038/s41598-025-14707-4.
2
Unravelling the myriad physiologic roles of transthyretin: critical considerations for treating transthyretin amyloidosis.揭示甲状腺素运载蛋白的众多生理作用:治疗甲状腺素运载蛋白淀粉样变性的关键考量因素
Ann Med. 2025 Dec;57(1):2536755. doi: 10.1080/07853890.2025.2536755. Epub 2025 Jul 27.
3
Realizing the therapeutic potential of rapid knockdown of transthyretin via RNA interference in transthyretin amyloidosis.

本文引用的文献

1
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.避免误诊:全科医生对转甲状腺素蛋白淀粉样变性的疑诊和诊断的专家共识建议。
BMC Fam Pract. 2020 Sep 23;21(1):198. doi: 10.1186/s12875-020-01252-4.
2
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.心脏淀粉样变性:不断发展的诊断和治疗——美国心脏协会的科学声明。
Circulation. 2020 Jul 7;142(1):e7-e22. doi: 10.1161/CIR.0000000000000792. Epub 2020 Jun 1.
3
Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.
通过RNA干扰快速敲低转甲状腺素蛋白在转甲状腺素蛋白淀粉样变性中的治疗潜力。
Mol Ther Nucleic Acids. 2025 Jun 10;36(3):102590. doi: 10.1016/j.omtn.2025.102590. eCollection 2025 Sep 9.
4
Transthyretin Amyloid Cardiomyopathy-2025 Update: Current Diagnostic Approaches and Emerging Therapeutic Options.转甲状腺素蛋白淀粉样心肌病-2025年更新:当前的诊断方法和新兴治疗选择
J Clin Med. 2025 Jul 7;14(13):4785. doi: 10.3390/jcm14134785.
5
Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS.在当代真实世界队列中,接受他氟米特治疗的混合型转甲状腺素蛋白淀粉样变心肌病患者的生存情况:来自THAOS的分析
Cardiol Ther. 2025 Jul 9. doi: 10.1007/s40119-025-00421-9.
6
Diagnostic pathway for cardiac amyloidosis from the healthcare professional's perspective: results from the French DIAM-ATTR survey.从医疗专业人员角度看心脏淀粉样变性的诊断途径:法国DIAM-ATTR调查结果
Ann Med. 2025 Dec;57(1):2525391. doi: 10.1080/07853890.2025.2525391. Epub 2025 Jun 30.
7
Hepatocyte Growth Factor: A Marker of Cardiac Function, Mortality, and Disease Subtype in Cardiac Amyloidosis.肝细胞生长因子:心脏淀粉样变性中的心功能、死亡率及疾病亚型标志物
JACC Adv. 2025 May 30;4(6 Pt 1):101828. doi: 10.1016/j.jacadv.2025.101828.
8
Beyond the Heart: Exploring Extracardiac Manifestations in Cardiac Amyloidosis for Early Diagnosis.超越心脏:探索心脏淀粉样变性的心脏外表现以实现早期诊断
Curr Cardiol Rep. 2025 Jun 25;27(1):105. doi: 10.1007/s11886-025-02251-6.
9
A Rare Culprit or an Elusive Culprit in Disguise? Unraveling Wild-Type ATTR Cardiac Amyloidosis in Heart Failure With Reduced Ejection Fraction.是罕见的罪魁祸首还是伪装成难以捉摸的罪魁祸首?揭开射血分数降低的心力衰竭中野生型转甲状腺素蛋白淀粉样变心肌病之谜。
J Investig Med High Impact Case Rep. 2025 Jan-Dec;13:23247096251345712. doi: 10.1177/23247096251345712. Epub 2025 May 30.
10
Early Amyloid Diagnosis and Treatment: Experience of Single Hand Surgeon With a Series of 182 Carpal Tunnel Biopsies.早期淀粉样变诊断与治疗:一位手外科医生对182例腕管活检病例的经验
Hand (N Y). 2025 Mar 29:15589447251326617. doi: 10.1177/15589447251326617.
APOLLO 研究中的生活质量结局:RNAi 治疗药物 patisiran 治疗遗传性转甲状腺素蛋白淀粉样变性的 3 期临床试验。
Amyloid. 2020 Sep;27(3):153-162. doi: 10.1080/13506129.2020.1730790. Epub 2020 Mar 4.
4
New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine.糖尿病神经病变的新视角:从外周到大脑,呼吁早期检测与精准医学。
Front Endocrinol (Lausanne). 2020 Jan 17;10:929. doi: 10.3389/fendo.2019.00929. eCollection 2019.
5
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.改善多发性神经病ATTR 淀粉样变症诊断的专家共识建议。
J Neurol. 2021 Jun;268(6):2109-2122. doi: 10.1007/s00415-019-09688-0. Epub 2020 Jan 6.
6
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis.依洛瑟那可维持或改善遗传性转甲状腺素蛋白淀粉样变性患者的生活质量。
J Neurol. 2020 Apr;267(4):1070-1079. doi: 10.1007/s00415-019-09671-9. Epub 2019 Dec 18.
7
Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.遗传性转甲状腺素淀粉样变性患者源性转甲状腺素蛋白衍生淀粉样纤维的冷冻电镜结构。
Nat Commun. 2019 Nov 1;10(1):5008. doi: 10.1038/s41467-019-13038-z.
8
Misdiagnosis of hATTR amyloidosis: a single US site experience.遗传性转甲状腺素蛋白淀粉样变性的误诊:美国单一机构的经验
Amyloid. 2020 Mar;27(1):69-70. doi: 10.1080/13506129.2019.1672649. Epub 2019 Oct 4.
9
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.专家共识建议:疑似转甲状腺素蛋白心脏淀粉样变性的诊断。
Circ Heart Fail. 2019 Sep;12(9):e006075. doi: 10.1161/CIRCHEARTFAILURE.119.006075. Epub 2019 Sep 4.
10
Carpal Tunnel Syndrome: A Potential Early, Red-Flag Sign of Amyloidosis.腕管综合征:淀粉样变性的一种潜在早期警示信号。
J Hand Surg Am. 2019 Oct;44(10):868-876. doi: 10.1016/j.jhsa.2019.06.016. Epub 2019 Aug 7.